Page last updated: 2024-11-06

homoserine lactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

homoserine lactone: a putative signal for starvation in E. coli; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

homoserinium lactone : The conjugate acid of homoserine lactone; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

homoserine lactone : A butan-4-olide having an amino substituent at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3973230
CHEBI ID58093
MeSH IDM0233944

Synonyms (10)

Synonym
alpha-amino-gamma-butyrolactone
HSL ,
homoserine lactone
2-oxotetrahydrofuran-3-aminium
homoserinium lactone cation
2-oxooxolan-3-aminium
homoserinium lactone
homoserinium lactone(1+)
CHEBI:58093
Q27125181

Research Excerpts

Dosage Studied

Microbial communities isolated from WBD-infected corals were exposed to quorum sensing inhibitor (QSI) QSI is a N-acyl homoserine lactone autoinducer antagonist. Dose-response curves using a LuxR-based AHL biosensor indicated that cyclo(DeltaAla-L-Val), Cyclo(L-Pro- L-Tyr) and cyclo (L-Phe-L -Pro) activate the biosensor in a concentration-dependent manner.

ExcerptRelevanceReference
" Dose-response curves using a LuxR-based AHL biosensor indicated that cyclo(DeltaAla-L-Val), cyclo(L-Pro-L-Tyr) and cyclo(L-Phe-L-Pro) activate the biosensor in a concentration-dependent manner, albeit at much higher concentrations than the natural activator N-(3-oxohexanoyl)-L-homoserine lactone (3-oxo-C6-HSL)."( Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria.
Bainton, NJ; Bycroft, BW; de Nys, R; England, D; Givskov, M; Hill, PJ; Holden, MT; Kjelleberg, S; Kumar, N; Labatte, M; Manefield, M; Ram Chhabra, S; Rice, S; Salmond, GP; Stead, P; Stewart, GS; Williams, P, 1999
)
0.3
" Although QS is reported to be largely related to the properties of activated sludge, it is not economically feasible to tune QS in an activated sludge reactor through dosing pure AHL or AHL hydrolase."( Augmentation of acyl homoserine lactones-producing and -quenching bacterium into activated sludge for its granulation.
Cao, JS; Fang, F; Li, WW; Li, YS; Pan, XR; Song, XN; Tong, ZH; Yu, HQ, 2017
)
0.46
" Microbial communities isolated from WBD-infected corals were exposed to quorum sensing inhibitor (QSI) - a N-acyl homoserine lactone autoinducer antagonist - and then dosed onto healthy test corals."( Inhibiting bacterial quorum sensing arrests coral disease development and disease-associated microbes.
Certner, RH; Vollmer, SV, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
ammonium ion derivativeA derivative of ammonium, NH4(+), in which one (or more) of the hydrogens bonded to the nitrogen have been replaced with univalent organyl groups. The substituting carbon of the organyl group must not itself be directly attached to a heteroatom (thereby excluding protonated amides, hemiaminals, etc).
organic cationAny organic ion with a net positive charge.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (742)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's41 (5.53)18.2507
2000's404 (54.45)29.6817
2010's242 (32.61)24.3611
2020's55 (7.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews82 (10.92%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other669 (89.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]